UniProt ID | PSA6_HUMAN | |
---|---|---|
UniProt AC | P60900 | |
Protein Name | Proteasome subunit alpha type-6 | |
Gene Name | PSMA6 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 246 | |
Subcellular Localization | Cytoplasm . Nucleus . Colocalizes with TRIM5 in cytoplasmic bodies. | |
Protein Description | Component of the 20S core proteasome complex involved in the proteolytic degradation of most intracellular proteins. This complex plays numerous essential roles within the cell by associating with different regulatory particles. Associated with two 19S regulatory particles, forms the 26S proteasome and thus participates in the ATP-dependent degradation of ubiquitinated proteins. The 26S proteasome plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins that could impair cellular functions, and by removing proteins whose functions are no longer required. Associated with the PA200 or PA28, the 20S proteasome mediates ubiquitin-independent protein degradation. This type of proteolysis is required in several pathways including spermatogenesis (20S-PA200 complex) or generation of a subset of MHC class I-presented antigenic peptides (20S-PA28 complex).. | |
Protein Sequence | MSRGSSAGFDRHITIFSPEGRLYQVEYAFKAINQGGLTSVAVRGKDCAVIVTQKKVPDKLLDSSTVTHLFKITENIGCVMTGMTADSRSQVQRARYEAANWKYKYGYEIPVDMLCKRIADISQVYTQNAEMRPLGCCMILIGIDEEQGPQVYKCDPAGYYCGFKATAAGVKQTESTSFLEKKVKKKFDWTFEQTVETAITCLSTVLSIDFKPSEIEVGVVTVENPKFRILTEAEIDAHLVALAERD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MSRGSSAGF ------CCCCCCCCC | 45.40 | 19413330 | |
2 | Phosphorylation | ------MSRGSSAGF ------CCCCCCCCC | 45.40 | 28450419 | |
3 | Methylation | -----MSRGSSAGFD -----CCCCCCCCCC | 47.95 | 115367909 | |
5 | O-linked_Glycosylation | ---MSRGSSAGFDRH ---CCCCCCCCCCCE | 18.86 | UniProtKB CARBOHYD | |
5 | Phosphorylation | ---MSRGSSAGFDRH ---CCCCCCCCCCCE | 18.86 | 22115753 | |
6 | Phosphorylation | --MSRGSSAGFDRHI --CCCCCCCCCCCEE | 34.92 | 21815630 | |
11 | Methylation | GSSAGFDRHITIFSP CCCCCCCCEEEEECC | 22.35 | 115489337 | |
14 | Phosphorylation | AGFDRHITIFSPEGR CCCCCEEEEECCCCC | 15.16 | 29396449 | |
17 | Phosphorylation | DRHITIFSPEGRLYQ CCEEEEECCCCCEEE | 20.42 | 25159151 | |
21 | Methylation | TIFSPEGRLYQVEYA EEECCCCCEEEEEEH | 28.67 | 115489345 | |
23 | Ubiquitination | FSPEGRLYQVEYAFK ECCCCCEEEEEEHHH | 14.78 | - | |
23 | Acetylation | FSPEGRLYQVEYAFK ECCCCCEEEEEEHHH | 14.78 | 19608861 | |
23 | Phosphorylation | FSPEGRLYQVEYAFK ECCCCCEEEEEEHHH | 14.78 | 28152594 | |
23 | Ubiquitination | FSPEGRLYQVEYAFK ECCCCCEEEEEEHHH | 14.78 | 19608861 | |
25 | Acetylation | PEGRLYQVEYAFKAI CCCCEEEEEEHHHHH | 3.72 | - | |
25 | Ubiquitination | PEGRLYQVEYAFKAI CCCCEEEEEEHHHHH | 3.72 | - | |
25 | Acetylation | PEGRLYQVEYAFKAI CCCCEEEEEEHHHHH | 3.72 | 19608861 | |
25 | Ubiquitination | PEGRLYQVEYAFKAI CCCCEEEEEEHHHHH | 3.72 | 19608861 | |
26 | Acetylation | EGRLYQVEYAFKAIN CCCEEEEEEHHHHHH | 18.67 | - | |
26 | Ubiquitination | EGRLYQVEYAFKAIN CCCEEEEEEHHHHHH | 18.67 | - | |
27 | Phosphorylation | GRLYQVEYAFKAINQ CCEEEEEEHHHHHHC | 20.62 | 28152594 | |
30 | Acetylation | YQVEYAFKAINQGGL EEEEEHHHHHHCCCC | 39.94 | 25953088 | |
30 | Methylation | YQVEYAFKAINQGGL EEEEEHHHHHHCCCC | 39.94 | 66700553 | |
30 | Ubiquitination | YQVEYAFKAINQGGL EEEEEHHHHHHCCCC | 39.94 | - | |
35 | Ubiquitination | AFKAINQGGLTSVAV HHHHHHCCCCEEEEE | 28.70 | - | |
36 | Acetylation | FKAINQGGLTSVAVR HHHHHCCCCEEEEEC | 18.93 | - | |
36 | Ubiquitination | FKAINQGGLTSVAVR HHHHHCCCCEEEEEC | 18.93 | - | |
37 | Acetylation | KAINQGGLTSVAVRG HHHHCCCCEEEEECC | 4.05 | - | |
37 | Ubiquitination | KAINQGGLTSVAVRG HHHHCCCCEEEEECC | 4.05 | - | |
40 | Acetylation | NQGGLTSVAVRGKDC HCCCCEEEEECCCCE | 4.87 | - | |
40 | Ubiquitination | NQGGLTSVAVRGKDC HCCCCEEEEECCCCE | 4.87 | - | |
45 | Acetylation | TSVAVRGKDCAVIVT EEEEECCCCEEEEEE | 38.78 | 23749302 | |
45 | Ubiquitination | TSVAVRGKDCAVIVT EEEEECCCCEEEEEE | 38.78 | 21906983 | |
52 | Ubiquitination | KDCAVIVTQKKVPDK CCEEEEEECCCCCHH | 24.44 | - | |
54 | 2-Hydroxyisobutyrylation | CAVIVTQKKVPDKLL EEEEEECCCCCHHHC | 46.50 | - | |
54 | Ubiquitination | CAVIVTQKKVPDKLL EEEEEECCCCCHHHC | 46.50 | - | |
55 | Acetylation | AVIVTQKKVPDKLLD EEEEECCCCCHHHCC | 49.54 | 23749302 | |
55 | Sumoylation | AVIVTQKKVPDKLLD EEEEECCCCCHHHCC | 49.54 | - | |
55 | Ubiquitination | AVIVTQKKVPDKLLD EEEEECCCCCHHHCC | 49.54 | 21906983 | |
59 | Ubiquitination | TQKKVPDKLLDSSTV ECCCCCHHHCCCCHH | 44.90 | 21890473 | |
59 | Ubiquitination | TQKKVPDKLLDSSTV ECCCCCHHHCCCCHH | 44.90 | 21890473 | |
59 | Acetylation | TQKKVPDKLLDSSTV ECCCCCHHHCCCCHH | 44.90 | 23749302 | |
59 | Ubiquitination | TQKKVPDKLLDSSTV ECCCCCHHHCCCCHH | 44.90 | 21906983 | |
63 | Phosphorylation | VPDKLLDSSTVTHLF CCHHHCCCCHHHHHH | 28.07 | 20068231 | |
64 | Phosphorylation | PDKLLDSSTVTHLFK CHHHCCCCHHHHHHH | 26.94 | 20068231 | |
65 | Phosphorylation | DKLLDSSTVTHLFKI HHHCCCCHHHHHHHH | 33.12 | 20068231 | |
67 | Phosphorylation | LLDSSTVTHLFKITE HCCCCHHHHHHHHHC | 16.98 | 23186163 | |
71 | Ubiquitination | STVTHLFKITENIGC CHHHHHHHHHCCCCE | 55.89 | - | |
73 | Phosphorylation | VTHLFKITENIGCVM HHHHHHHHCCCCEEE | 24.46 | - | |
78 | Glutathionylation | KITENIGCVMTGMTA HHHCCCCEEEECCCC | 1.35 | 22555962 | |
80 | Sulfoxidation | TENIGCVMTGMTADS HCCCCEEEECCCCCC | 2.89 | 30846556 | |
81 | Phosphorylation | ENIGCVMTGMTADSR CCCCEEEECCCCCCH | 11.91 | 27251275 | |
83 | Acetylation | IGCVMTGMTADSRSQ CCEEEECCCCCCHHH | 1.73 | 19608861 | |
83 | Sulfoxidation | IGCVMTGMTADSRSQ CCEEEECCCCCCHHH | 1.73 | 30846556 | |
83 | Ubiquitination | IGCVMTGMTADSRSQ CCEEEECCCCCCHHH | 1.73 | 19608861 | |
84 | Phosphorylation | GCVMTGMTADSRSQV CEEEECCCCCCHHHH | 28.76 | 27251275 | |
85 | Ubiquitination | CVMTGMTADSRSQVQ EEEECCCCCCHHHHH | 12.14 | - | |
85 | Acetylation | CVMTGMTADSRSQVQ EEEECCCCCCHHHHH | 12.14 | 19608861 | |
85 | Ubiquitination | CVMTGMTADSRSQVQ EEEECCCCCCHHHHH | 12.14 | 19608861 | |
92 | Ubiquitination | ADSRSQVQRARYEAA CCCHHHHHHHHHHHH | 26.19 | - | |
96 | Phosphorylation | SQVQRARYEAANWKY HHHHHHHHHHHCCHH | 14.67 | 23917254 | |
102 | Acetylation | RYEAANWKYKYGYEI HHHHHCCHHHCCCCC | 31.50 | - | |
102 | Ubiquitination | RYEAANWKYKYGYEI HHHHHCCHHHCCCCC | 31.50 | 21890473 | |
102 | Ubiquitination | RYEAANWKYKYGYEI HHHHHCCHHHCCCCC | 31.50 | 21890473 | |
102 | 2-Hydroxyisobutyrylation | RYEAANWKYKYGYEI HHHHHCCHHHCCCCC | 31.50 | - | |
102 | Acetylation | RYEAANWKYKYGYEI HHHHHCCHHHCCCCC | 31.50 | 19608861 | |
102 | Methylation | RYEAANWKYKYGYEI HHHHHCCHHHCCCCC | 31.50 | 22648033 | |
102 | Succinylation | RYEAANWKYKYGYEI HHHHHCCHHHCCCCC | 31.50 | 23954790 | |
102 | Sumoylation | RYEAANWKYKYGYEI HHHHHCCHHHCCCCC | 31.50 | 19608861 | |
102 | Ubiquitination | RYEAANWKYKYGYEI HHHHHCCHHHCCCCC | 31.50 | 21890473 | |
103 | Ubiquitination | YEAANWKYKYGYEIP HHHHCCHHHCCCCCC | 10.89 | - | |
103 | Phosphorylation | YEAANWKYKYGYEIP HHHHCCHHHCCCCCC | 10.89 | 28152594 | |
104 | Ubiquitination | EAANWKYKYGYEIPV HHHCCHHHCCCCCCH | 28.59 | 21890473 | |
104 | Ubiquitination | EAANWKYKYGYEIPV HHHCCHHHCCCCCCH | 28.59 | 21890473 | |
104 | 2-Hydroxyisobutyrylation | EAANWKYKYGYEIPV HHHCCHHHCCCCCCH | 28.59 | - | |
104 | Acetylation | EAANWKYKYGYEIPV HHHCCHHHCCCCCCH | 28.59 | 19608861 | |
104 | Malonylation | EAANWKYKYGYEIPV HHHCCHHHCCCCCCH | 28.59 | 26320211 | |
104 | Ubiquitination | EAANWKYKYGYEIPV HHHCCHHHCCCCCCH | 28.59 | 21890473 | |
105 | Phosphorylation | AANWKYKYGYEIPVD HHCCHHHCCCCCCHH | 23.11 | 20090780 | |
107 | Phosphorylation | NWKYKYGYEIPVDML CCHHHCCCCCCHHHH | 13.95 | 28152594 | |
113 | Sulfoxidation | GYEIPVDMLCKRIAD CCCCCHHHHHHHHHH | 4.88 | 30846556 | |
115 | Glutathionylation | EIPVDMLCKRIADIS CCCHHHHHHHHHHHH | 1.92 | 22555962 | |
116 | 2-Hydroxyisobutyrylation | IPVDMLCKRIADISQ CCHHHHHHHHHHHHH | 42.76 | - | |
116 | Acetylation | IPVDMLCKRIADISQ CCHHHHHHHHHHHHH | 42.76 | 23749302 | |
116 | Ubiquitination | IPVDMLCKRIADISQ CCHHHHHHHHHHHHH | 42.76 | - | |
153 | Ubiquitination | EQGPQVYKCDPAGYY CCCCCEEEECCCCCC | 33.05 | - | |
154 | S-nitrosocysteine | QGPQVYKCDPAGYYC CCCCEEEECCCCCCC | 4.08 | - | |
154 | S-nitrosylation | QGPQVYKCDPAGYYC CCCCEEEECCCCCCC | 4.08 | 19483679 | |
159 | Phosphorylation | YKCDPAGYYCGFKAT EEECCCCCCCCEEEE | 9.55 | 20090780 | |
160 | Phosphorylation | KCDPAGYYCGFKATA EECCCCCCCCEEEEE | 5.79 | 21082442 | |
161 | S-nitrosocysteine | CDPAGYYCGFKATAA ECCCCCCCCEEEEEC | 3.78 | - | |
161 | S-nitrosylation | CDPAGYYCGFKATAA ECCCCCCCCEEEEEC | 3.78 | 19483679 | |
162 | Acetylation | DPAGYYCGFKATAAG CCCCCCCCEEEEECC | 15.80 | 19608861 | |
162 | Ubiquitination | DPAGYYCGFKATAAG CCCCCCCCEEEEECC | 15.80 | 19608861 | |
164 | Acetylation | AGYYCGFKATAAGVK CCCCCCEEEEECCCC | 30.06 | 25953088 | |
164 | Ubiquitination | AGYYCGFKATAAGVK CCCCCCEEEEECCCC | 30.06 | 21906983 | |
171 | 2-Hydroxyisobutyrylation | KATAAGVKQTESTSF EEEECCCCCCCCCCH | 51.05 | - | |
171 | Acetylation | KATAAGVKQTESTSF EEEECCCCCCCCCCH | 51.05 | 25953088 | |
171 | Malonylation | KATAAGVKQTESTSF EEEECCCCCCCCCCH | 51.05 | 26320211 | |
171 | Ubiquitination | KATAAGVKQTESTSF EEEECCCCCCCCCCH | 51.05 | - | |
173 | Phosphorylation | TAAGVKQTESTSFLE EECCCCCCCCCCHHH | 26.62 | 26437602 | |
175 | Phosphorylation | AGVKQTESTSFLEKK CCCCCCCCCCHHHHH | 32.51 | 30622161 | |
176 | Phosphorylation | GVKQTESTSFLEKKV CCCCCCCCCHHHHHH | 19.77 | 28348404 | |
177 | Phosphorylation | VKQTESTSFLEKKVK CCCCCCCCHHHHHHH | 36.79 | 27050516 | |
181 | 2-Hydroxyisobutyrylation | ESTSFLEKKVKKKFD CCCCHHHHHHHHHCC | 66.08 | - | |
181 | Acetylation | ESTSFLEKKVKKKFD CCCCHHHHHHHHHCC | 66.08 | 23954790 | |
181 | Ubiquitination | ESTSFLEKKVKKKFD CCCCHHHHHHHHHCC | 66.08 | 21906983 | |
182 | Ubiquitination | STSFLEKKVKKKFDW CCCHHHHHHHHHCCC | 50.33 | - | |
211 | Ubiquitination | TVLSIDFKPSEIEVG HHHCCCCCCCEEEEE | 43.84 | - | |
213 | Phosphorylation | LSIDFKPSEIEVGVV HCCCCCCCEEEEEEE | 52.36 | 24719451 | |
231 | Phosphorylation | NPKFRILTEAEIDAH CCCEEEEEHHHHHHH | 30.67 | - | |
245 | Methylation | HLVALAERD------ HHHHHHCCC------ | 49.70 | 115489353 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PSA6_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PSA6_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PSA6_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-102 AND LYS-104, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-160, AND MASSSPECTROMETRY. | |
Ubiquitylation | |
Reference | PubMed |
"Tryptic digestion of ubiquitin standards reveals an improved strategyfor identifying ubiquitinated proteins by mass spectrometry."; Denis N.J., Vasilescu J., Lambert J.-P., Smith J.C., Figeys D.; Proteomics 7:868-874(2007). Cited for: UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-59, AND MASSSPECTROMETRY. |